Norges Bank’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
RCMNY
MCMC
AIM
NAMA
Norges Bank's ADPT Position: Q2 2024 in Review
Norges Bank sold out of Adaptive Biotechnologies (ADPT) in Q2 2024, closing a stake of 103,311 shares — an estimated $332K sold.
Norges Bank first reported a position in ADPT in Q2 2019 and held it in 20 quarters. The position peaked at $49M in Q4 2020. 176 funds tracked by Wall St. Rank hold ADPT as of Q2 2024.
- Norges Bank reported no remaining Adaptive Biotechnologies position as of Q2 2024 after selling out during the quarter.
- Norges Bank sold 103,311 Adaptive Biotechnologies shares in Q2 2024, an estimated $332K.
- Norges Bank first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 20 quarters.
- Norges Bank's Adaptive Biotechnologies position peaked at $49M in Q4 2020.
- 176 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2024.
Based on Norges Bank's 13F filing for Q2 2024, filed 14 Aug 2024.